Related references
Note: Only part of the references are listed.Clinical Stage Migration and Survival for Renal Cell Carcinoma in the United States
Hiten D. Patel et al.
EUROPEAN UROLOGY ONCOLOGY (2019)
Updated European Association of Urology Guidelines: Recommendations for the Treatment of First-line Metastatic Clear Cell Renal Cancer
Thomas Powles et al.
EUROPEAN UROLOGY (2018)
Updates to the Management of Kidney Cancer
Eric Jonasch
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
Comparison of Pathological Stage in Patients Treated with and without Neoadjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma
Ross S. Liao et al.
JOURNAL OF UROLOGY (2018)
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
P. M. Forde et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Incidence of T3a up-staging and survival after partial nephrectomy: Size-stratified rates and implications for prognosis
Arnav Srivastava et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2018)
Axitinib versus placebo as an adjuvant treatment of renal cell carcinoma: results from the phase III, randomized ATLAS trial
M. Gross-Goupil et al.
ANNALS OF ONCOLOGY (2018)
Surgical Management of Advanced Kidney Cancer: The Role of Cytoreductive Nephrectomy and Lymphadenectomy
Hiten D. Patel et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study
Andrea Necchi et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Evaluation of Disease-Free Survival as an Intermediate Metric of Overall Survival in Patients With Localized Renal Cell Carcinoma: A Trial-Level Meta-Analysis
Lauren C. Harshman et al.
CANCER (2018)
Updated European Association of Urology Guidelines Regarding Adjuvant Therapy for Renal Cell Carcinoma
Axel Bex et al.
EUROPEAN UROLOGY (2017)
Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma
Robert J. Motzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Systemic Therapy for Metastatic Renal-Cell Carcinoma
Toni K. Choueiri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Pathologic response in patients receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer: Is therapeutic effect owing to chemotherapy or TURBT?
Aaron Brant et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2017)
Adjuvant Treatment for High-Risk Clear Cell Renal Cancer Updated Results of a High-Risk Subset of the ASSURE Randomized Trial
Naomi B. Haas et al.
JAMA ONCOLOGY (2017)
Transforming the Perioperative Treatment Paradigm in Non-Metastatic RCC-A Possible Path Forward
L. C. Harshman et al.
KIDNEY CANCER (2017)
Distinguishing Malignant and Benign Renal Masses With Composite Models and Nomograms: A Systematic Review and Meta-Analysis of Clinically Localized Renal Masses Suspicious for Malignancy
Phillip M. Pierorazio et al.
CANCER (2016)
Diagnostic Accuracy and Risks of Biopsy in the Diagnosis of a Renal Mass Suspicious for Localized Renal Cell Carcinoma: Systematic Review of the Literature
Hiten D. Patel et al.
JOURNAL OF UROLOGY (2016)
Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial
Naomi B. Haas et al.
LANCET (2016)
Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy
A. Ravaud et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
A Systematic Review of Research Gaps in the Evaluation and Management of Localized Renal Masses
Hiten D. Patel et al.
UROLOGY (2016)
Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease
Jing Liu et al.
CANCER DISCOVERY (2016)
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Targeting PD-1/PD-L1 in the treatment of metastatic renal cell carcinoma
Matthew Weinstock et al.
THERAPEUTIC ADVANCES IN UROLOGY (2015)
Characteristics and Clinical Impacts of the Immune Environments in Colorectal and Renal Cell Carcinoma Lung Metastases: Influence of Tumor Origin
Romain Remark et al.
CLINICAL CANCER RESEARCH (2013)
Epidemiology and risk factors for kidney cancer
Wong-Ho Chow et al.
NATURE REVIEWS UROLOGY (2010)
Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer
HB Grossman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Randomized, placebo-controlled trial of clodronate in patients with primary operable breast cancer
T Powles et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Share Paper
